LAPELGA Trademark

Trademark Overview

On Monday, January 14, 2019, a trademark application was filed for LAPELGA with the United States Patent and Trademark Office. The USPTO has given the LAPELGA trademark a serial number of 88260489. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 12, 2021. This trademark is owned by Apotex Technologies Inc.. The LAPELGA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for hematopoietic growth factors; pharmaceutical preparations, namely, recombinant-human granulocyte-CSF for use in stimulating white blood cell production
lapelga

General Information

Serial Number88260489
Word MarkLAPELGA
Filing DateMonday, January 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 12, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 14, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for hematopoietic growth factors; pharmaceutical preparations, namely, recombinant-human granulocyte-CSF for use in stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 5, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameACCORD BIOPHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDURHAM, NC 27703
Party NameApotex Technologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9L1T9
CA

Trademark Events

Event DateEvent Description
Monday, April 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 12, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 24, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 11, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 2, 2020ASSIGNED TO LIE
Tuesday, May 26, 2020ASSIGNED TO LIE
Tuesday, May 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 19, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, April 15, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 18, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 16, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 14, 2019ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Tuesday, May 14, 2019WITHDRAWN FROM ISSUE - INCOMING CORR RECEIVED
Tuesday, May 14, 2019ASSIGNED TO PETITION STAFF
Tuesday, May 14, 2019ASSIGNED TO PETITION STAFF
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, March 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2019ASSIGNED TO EXAMINER
Tuesday, February 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 17, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

lapelga pharmaceutical preparations white stimulating cell production granulocyte blood recombinant hematopoietic